Immunome (IMNM)
Develops targeted oncology drugs across ADCs, radioligands and small molecules.
$27.32
At close+0.26 (+0.94%)
Something off on this page? Send us feedback.
Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$0.64
Revenue estimate
$181.8K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported−$0.52−$0.50−$0.65−$0.75−$0.48−$0.65−$0.65Pending
Estimate−$0.66−$0.52−$0.57−$0.59−$0.60−$0.51−$0.51−$0.64
Surprise+21.2%+3.8%−14.0%−27.1%+20.0%−26.5%−26.5%—
RevenueReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported$2.9M$4.0M—————Pending
Estimate$457.1K$833.3K$850.0K$876.0K$222.2K$166.7K$166.7K$181.8K
Surprise+540.1%+381.8%——————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.64 | — | — |
| Aug 2026 | −$0.51 | −$0.65 | −26.5% |
| Aug 2026 | −$0.51 | −$0.65 | −26.5% |
| May 2026 | −$0.60 | −$0.48 | +20.0% |
| Mar 2026 | −$0.59 | −$0.75 | −27.1% |
The latest year is open to everyone — the 27 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Oct 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.64 | — | — | $181.8K | — | — | — |
| Aug 12, 2026 | −$0.51 | −$0.65 | −26.5% | $166.7K | — | — | −5.6% |
| Aug 11, 2026 | −$0.51 | −$0.65 | −26.5% | $166.7K | — | — | +6.6% |
| May 12, 2026 | −$0.60 | −$0.48 | +20.0% | $222.2K | — | — | −2.2% |
| Mar 3, 2026 | −$0.59 | −$0.75 | −27.1% | $876.0K | — | — | +4.6% |
The latest year is open to everyone — the 27 quarters behind it read with an account. Sign in | |||||||
| Nov 6, 2025 | |||||||
| Aug 6, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 19, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 5, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 5, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 28, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 12, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Oct 5, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||